N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase. 1988

F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
Istituto di Genetica Biochimica ed Evoluzionistica, CNR, Pavia, Italy.

A series of N2-substituted guanine derivatives was screened against mammalian thymidine kinase and the thymidine kinase encoded by type I herpes simplex virus to examine their capacity to selectivity inhibit the viral enzyme. Several bases, nucleosides, and nucleotides displayed selective activity. The mechanism of action of the most potent derivative, N2-phenyl-2'-deoxyguanosine (PhdG) was studied in detail. PhdG (a) inhibited the viral enzyme competitively with respect to the substrates thymidine and deoxycytidine, (b) was completely resistant to phosphorylation, (c) displayed limited toxicity for the HeLa cell lines employed as hosts for viral infection, and (d) selectively inhibited viral thymidine kinase function in intact cultured cells. The results indicate that the PhdG drug prototype has potential as a selective anti-herpes agent and as a novel molecular probe of the structure and function of herpes simplex thymidine kinase.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D003849 Deoxyguanosine A nucleoside consisting of the base guanine and the sugar deoxyribose.
D006147 Guanine
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013937 Thymidine Kinase An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21. Deoxythymidine Kinase,Deoxypyrimidine Kinase,Kinase, Deoxypyrimidine,Kinase, Deoxythymidine,Kinase, Thymidine
D018139 Simplexvirus A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. Herpes Simplex Virus,Herpesvirus 1, Saimiriine,Herpesvirus 1, Saimirine,Herpesvirus 16, Cercopithecine,Marmoset Virus,Cercopithecine Herpesvirus 16,Herpes Labialis Virus,Herpes-T Virus,Herpesvirus 1 (alpha), Saimirine,Herpesvirus Hominis,Herpesvirus Papio 2,Herpesvirus Platyrhinae,Marmoset Herpesvirus,Saimiriine Herpesvirus 1,Herpes Labialis Viruses,Herpes Simplex Viruses,Herpes T Virus,Herpes-T Viruses,Herpesvirus Homini,Herpesvirus, Marmoset,Herpesviruses, Marmoset,Homini, Herpesvirus,Hominis, Herpesvirus,Labialis Virus, Herpes,Labialis Viruses, Herpes,Marmoset Herpesviruses,Marmoset Viruses,Platyrhinae, Herpesvirus,Saimirine Herpesvirus 1,Simplexviruses,Virus, Herpes Labialis,Viruses, Herpes Labialis

Related Publications

F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
August 1979, Journal of virology,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
December 1995, Die Pharmazie,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
September 1992, Antimicrobial agents and chemotherapy,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
April 2015, Antiviral chemistry & chemotherapy,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
June 1974, Biochemical and biophysical research communications,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
June 1996, Nucleic acids research,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
January 1982, Virology,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
May 1996, Antiviral research,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
November 1999, Bone marrow transplantation,
F Focher, and C Hildebrand, and S Freese, and G Ciarrocchi, and T Noonan, and S Sangalli, and N Brown, and S Spadari, and G Wright
September 1984, The Journal of general virology,
Copied contents to your clipboard!